Millipore Sigma Vibrant Logo

553210 Rapamycin - CAS 53123-88-9 - Calbiochem

This product can no longer be ordered through emdmillipore.com. Please refer to (Cat. No. 553210) on sigmaaldrich.com.

Rapamycin - CAS 53123-88-9 - Calbiochem: Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: mTOR Inhibitor I

Primary Target: Mammalian target of rapamycin (mTOR)
View Products on Sigmaaldrich.com
553210
Ver precios y disponibilidad

Descripción

Replacement Information

Tabla espec. clave

CAS #Empirical Formula
53123-88-9C₅₁H₇₉NO₁₃

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
553210-100UG
Comprobando disponibilidad...
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      		 Ampolla de plást. 100 μg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      —
      Solicitar precio
      		 —
      553210-10MG
      Comprobando disponibilidad...
      —
      Disponibilidad a confirmar Disponibilidad a confirmar
      Ingrese cantidad 
      Suspendido
      Cantidades limitadas disponibles
      Debe confirmarse disponibilidad
        El resto: se avisará
          El resto: se avisará
          Se avisará
          Póngase en contacto con el Servicio de Atención al Cliente
          Contact Customer Service

          		 Frasco de vidrio 10 mg
          Recuperando precio...
          No pudo obtenerse el precio
          La cantidad mínima tiene que ser múltiplo de
          Maximum Quantity is
          Al finalizar el pedido Más información
          Ahorró ()
           
          —
          Solicitar precio
          		 —
          553210-1MG
          Comprobando disponibilidad...
          —
          Disponibilidad a confirmar Disponibilidad a confirmar
          Ingrese cantidad 
          Suspendido
          Cantidades limitadas disponibles
          Debe confirmarse disponibilidad
            El resto: se avisará
              El resto: se avisará
              Se avisará
              Póngase en contacto con el Servicio de Atención al Cliente
              Contact Customer Service

              		 Ampolla de plást. 1 mg
              Recuperando precio...
              No pudo obtenerse el precio
              La cantidad mínima tiene que ser múltiplo de
              Maximum Quantity is
              Al finalizar el pedido Más información
              Ahorró ()
               
              —
              Solicitar precio
              		 —
              553210-5MG
              Comprobando disponibilidad...
              —
              Disponibilidad a confirmar Disponibilidad a confirmar
              Ingrese cantidad 
              Suspendido
              Cantidades limitadas disponibles
              Debe confirmarse disponibilidad
                El resto: se avisará
                  El resto: se avisará
                  Se avisará
                  Póngase en contacto con el Servicio de Atención al Cliente
                  Contact Customer Service

                  		 Frasco de vidrio 5 mg
                  Recuperando precio...
                  No pudo obtenerse el precio
                  La cantidad mínima tiene que ser múltiplo de
                  Maximum Quantity is
                  Al finalizar el pedido Más información
                  Ahorró ()
                   
                  —
                  Solicitar precio
                  		 —
                  Description
                  OverviewAnti-fungal and immunosuppressant. Selectively inhibits the mammalian target of rapamycin (mTOR) and blocks the subsequent activation of p70 S6 kinase (IC50 = 50 pM). Specifically inhibits mTORC1, but mTORC2 that phosphorylates Akt at Ser473 appears to be insensitive to rapamycin. Prevents the translational activation of IGF-II. Also prevents resting T-cells from entering the cell cycle, but does not directly arrest cell cycle progression. Shown to inhibit later signaling events, such as p110Rb phosphorylation, p34cdc2 kinase activation, and cyclin A synthesis. Exhibits strong binding to FK-506 binding proteins. Also reported to induce apoptosis in a murine B-cell line, to inhibit lymphokine-induced cell proliferation at the G1 phase, and to irreversibly arrest Saccharomyces cerevisiae cells in the G1 phase. A 5 mM (500 µg/109 µl) solution of Rapamycin (Cat. No. 553211) in DMSO and a 10 mM (1 mg/109 µl) solution of Rapamycin (Cat. No. 553212) in EtOH is also available.
                  Catalogue Number553210
                  Brand Family Calbiochem®
                  SynonymsmTOR Inhibitor I
                  References
                  ReferencesChen, T., et al. 2011. Aging Cell. 10, 908.
                  Powell, D.J., et al. 2003. Mol. cell Biol. 23, 7794.
                  Braun, W., et al. 1995. FASEB J. 9, 63.
                  Nielsen, F.C., et al. 1995. Nature 377, 358.
                  Aagaard-Tillery, K.M. and Jelinek, D.F. 1994. Cell. Immunol. 156, 493.
                  Gottschalk, A.R., et al. 1994. Proc. Natl. Acad. Sci. USA 91, 7350.
                  Morice, W.G., et al. 1993. J. Biol. Chem. 268, 3734.
                  Terada, N., et al. 1993. J. Biol. Chem. 268, 12062.
                  Kuo, J., et al. 1992. Nature 358, 70.
                  Price, D.J., et al. 1992. Science 257, 973.
                  Heitman, J., et al. 1991. Science 253, 905.
                  Kay, J.E., et al. 1991. Immunology 72, 544.
                  Schreiber, S.L. 1991. Science 251, 283.
                  Bierer, B.E., et al. 1990. Proc. Natl. Acad. Sci. USA 87, 9231.
                  Dumont, F.J., et al. 1990. J. Immunol. 144, 251.
                  Product Information
                  CAS number53123-88-9
                  ATP CompetitiveN
                  FormClear film
                  Hill FormulaC₅₁H₇₉NO₁₃
                  Chemical formulaC₅₁H₇₉NO₁₃
                  ReversibleN
                  Structure formula ImageStructure formula Image
                  Quality LevelMQ200
                  Applications
                  Biological Information
                  Primary TargetMammalian target of rapamycin (mTOR)
                  Primary Target IC<sub>50</sub>50 pM against p70 S6 kinase
                  Purity≥99% by HPLC
                  Physicochemical Information
                  Cell permeableN
                  Dimensions
                  Materials Information
                  Toxicological Information
                  Safety Information according to GHS
                  RTECSVE6250000
                  Safety Information
                  Product Usage Statements
                  Storage and Shipping Information
                  Ship Code Ambient Temperature Only
                  Toxicity Standard Handling
                  Storage -20°C
                  Do not freeze Ok to freeze
                  Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
                  Packaging Information
                  Transport Information
                  Supplemental Information
                  Specifications
                  Global Trade Item Number
                  Número de referencia GTIN
                  553210-100UG 04055977193510
                  553210-10MG 07790788060305
                  553210-1MG 04055977193480
                  553210-5MG 04055977193534

                  Documentation

                  Rapamycin - CAS 53123-88-9 - Calbiochem Ficha datos de seguridad (MSDS)

                  Título

                  Ficha técnica de seguridad del material (MSDS) 

                  Rapamycin - CAS 53123-88-9 - Calbiochem Certificados de análisis

                  CargoNúmero de lote
                  553210

                  Referencias bibliográficas

                  Visión general referencias
                  Chen, T., et al. 2011. Aging Cell. 10, 908.
                  Powell, D.J., et al. 2003. Mol. cell Biol. 23, 7794.
                  Braun, W., et al. 1995. FASEB J. 9, 63.
                  Nielsen, F.C., et al. 1995. Nature 377, 358.
                  Aagaard-Tillery, K.M. and Jelinek, D.F. 1994. Cell. Immunol. 156, 493.
                  Gottschalk, A.R., et al. 1994. Proc. Natl. Acad. Sci. USA 91, 7350.
                  Morice, W.G., et al. 1993. J. Biol. Chem. 268, 3734.
                  Terada, N., et al. 1993. J. Biol. Chem. 268, 12062.
                  Kuo, J., et al. 1992. Nature 358, 70.
                  Price, D.J., et al. 1992. Science 257, 973.
                  Heitman, J., et al. 1991. Science 253, 905.
                  Kay, J.E., et al. 1991. Immunology 72, 544.
                  Schreiber, S.L. 1991. Science 251, 283.
                  Bierer, B.E., et al. 1990. Proc. Natl. Acad. Sci. USA 87, 9231.
                  Dumont, F.J., et al. 1990. J. Immunol. 144, 251.

                  Folleto

                  Cargo
                  Bulk Product Guide
                  Caspases and other Apoptosis Related Tools Brochure

                  Ficha técnica

                  Cargo
                  Reprogramming Cell Fate and Function Novel Strategies for iPSC Generation, Characterization, and Differentiation

                  Póster

                  Cargo
                  Human Kinome & InhibitorSelect™ Libraries

                  Citas

                  Título
                • Chen, T., et al. 2011. Aging Cell. 10, 908.
                • Yu, YL., et al. 2005. Journal of Biological Chemistry 280, 29533.
                • Vega, R.B., et al. 2004. Molecular and Cellular Biology 24, 8374.
                • Liao, X., et al. 2003. Endocrinology 144, 1656.
                  		•
                  Ficha técnica

                  Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

                  Revision11-September-2014 JSW
                  SynonymsmTOR Inhibitor I
                  DescriptionSelectively inhibits the mammalian target of rapamycin (mTOR) and blocks the subsequent activation of p70 S6 kinase (IC50 = 50 pM). Specifically inhibits mTORC1, but mTORC2 that phosphorylates Akt at Ser473 appears to be insensitive to rapamycin. Prevents the translational activation of IGF-II. Also prevents resting T-cells from entering the cell cycle, but does not directly arrest cell cycle progression. Shown to inhibit later signaling events, such as p110Rb phosphorylation, p34cdc2 kinase activation, and cyclin A synthesis. Exhibits strong binding to FK-506 binding proteins. Also reported to induce apoptosis in a murine B-cell line, to inhibit lymphokine-induced cell proliferation at the G1 phase, and to irreversibly arrest Saccharomyces cerevisiae cells in the G1 phase.
                  FormClear film
                  CAS number53123-88-9
                  RTECSVE6250000
                  Chemical formulaC₅₁H₇₉NO₁₃
                  Structure formulaStructure formula
                  Purity≥99% by HPLC
                  SolubilityDMSO (200 mg/ml) or Ethanol (50 mg/ml)
                  Storage -20°C
                  Do Not Freeze Ok to freeze
                  Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
                  Toxicity Standard Handling
                  Merck USA index14, 8114
                  ReferencesChen, T., et al. 2011. Aging Cell. 10, 908.
                  Powell, D.J., et al. 2003. Mol. cell Biol. 23, 7794.
                  Braun, W., et al. 1995. FASEB J. 9, 63.
                  Nielsen, F.C., et al. 1995. Nature 377, 358.
                  Aagaard-Tillery, K.M. and Jelinek, D.F. 1994. Cell. Immunol. 156, 493.
                  Gottschalk, A.R., et al. 1994. Proc. Natl. Acad. Sci. USA 91, 7350.
                  Morice, W.G., et al. 1993. J. Biol. Chem. 268, 3734.
                  Terada, N., et al. 1993. J. Biol. Chem. 268, 12062.
                  Kuo, J., et al. 1992. Nature 358, 70.
                  Price, D.J., et al. 1992. Science 257, 973.
                  Heitman, J., et al. 1991. Science 253, 905.
                  Kay, J.E., et al. 1991. Immunology 72, 544.
                  Schreiber, S.L. 1991. Science 251, 283.
                  Bierer, B.E., et al. 1990. Proc. Natl. Acad. Sci. USA 87, 9231.
                  Dumont, F.J., et al. 1990. J. Immunol. 144, 251.
                  Citation
                • Chen, T., et al. 2011. Aging Cell. 10, 908.
                • Yu, YL., et al. 2005. Journal of Biological Chemistry 280, 29533.
                • Vega, R.B., et al. 2004. Molecular and Cellular Biology 24, 8374.
                • Liao, X., et al. 2003. Endocrinology 144, 1656.
                  		•